Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Receives $27.33 Consensus Target Price from Brokerages

Key Points

• Kestra Medical Technologies, Ltd. has an average rating of "Moderate Buy" from six brokerages, with one hold rating and five buy ratings among its analysts.
• The average price target for the stock is $27.33, although Goldman Sachs and Wells Fargo have recently downgraded their estimates to $23.00 and $27.00 respectively.
• Shares of Kestra Medical Technologies opened at $15.38, with a twelve-month price range between $13.25 and $26.15.

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six ratings firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $27.3333.

Several brokerages recently weighed in on KMTS. The Goldman Sachs Group lowered their price objective on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating for the company in a research report on Wednesday, April 16th. Wells Fargo & Company dropped their price target on shares of Kestra Medical Technologies from $28.00 to $27.00 and set an "overweight" rating for the company in a research report on Thursday, July 17th.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in KMTS. Brown Advisory Inc. purchased a new stake in Kestra Medical Technologies in the 1st quarter valued at $13,716,000. Caas Capital Management LP purchased a new position in Kestra Medical Technologies during the 1st quarter valued at about $1,470,000. Jennison Associates LLC purchased a new position in shares of Kestra Medical Technologies during the 1st quarter worth approximately $1,869,000. TD Asset Management Inc acquired a new stake in shares of Kestra Medical Technologies during the 1st quarter worth about $2,306,000. Finally, Federated Hermes Inc. acquired a new stake in shares of Kestra Medical Technologies in the first quarter worth $9,968,000.

Kestra Medical Technologies Stock Up 1.6%

Shares of KMTS stock traded up $0.23 during trading hours on Friday, hitting $14.69. The company's stock had a trading volume of 225,828 shares, compared to its average volume of 283,685. The stock has a 50 day simple moving average of $17.08. The company has a debt-to-equity ratio of 0.20, a current ratio of 6.72 and a quick ratio of 6.72. Kestra Medical Technologies has a 12-month low of $13.25 and a 12-month high of $26.15.

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.